BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24366076)

  • 21. Macrophage migration inhibitory factor knockout attenuates endotoxin-induced cardiac dysfunction in mice.
    Zhang J; Zhang X; Cui Y; Cui L; Zhao P
    Kardiol Pol; 2018; 76(5):871-880. PubMed ID: 29350381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
    Gesmundo I; Miragoli M; Carullo P; Trovato L; Larcher V; Di Pasquale E; Brancaccio M; Mazzola M; Villanova T; Sorge M; Taliano M; Gallo MP; Alloatti G; Penna C; Hare JM; Ghigo E; Schally AV; Condorelli G; Granata R
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12033-12038. PubMed ID: 29078377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy mediates the secretion of macrophage migration inhibitory factor from cardiomyocytes upon serum-starvation.
    Wu J; Deng X; Gao J; Gao W; Xiao H; Wang X; Zhang Y
    Sci China Life Sci; 2019 Aug; 62(8):1038-1046. PubMed ID: 31209799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage migration inhibitory factor induces contractile and mitochondria dysfunction by altering cytoskeleton network in the human heart.
    Preau S; Montaigne D; Modine T; Fayad G; Koussa M; Tardivel M; Durocher A; Saulnier F; Marechal X; Neviere R
    Crit Care Med; 2013 Jul; 41(7):e125-33. PubMed ID: 23478658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy.
    Xiao Y; Yang Z; Wu QQ; Jiang XH; Yuan Y; Chang W; Bian ZY; Zhu JX; Tang QZ
    J Cell Biochem; 2017 Nov; 118(11):3899-3910. PubMed ID: 28390176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation.
    Gao XM; Liu Y; White D; Su Y; Drew BG; Bruce CR; Kiriazis H; Xu Q; Jennings N; Bobik A; Febbraio MA; Kingwell BA; Bucala R; Fingerle-Rowson G; Dart AM; Morand EF; Du XJ
    J Mol Cell Cardiol; 2011 Jun; 50(6):991-9. PubMed ID: 21215754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.
    Wang X; Cui T
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H304-H319. PubMed ID: 28576834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K/Akt/mTOR and AMPK pathways.
    Cui J; Zhang F; Wang Y; Liu J; Ming X; Hou J; Lv B; Fang S; Yu B
    Int J Mol Med; 2016 May; 37(5):1299-309. PubMed ID: 27035848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p.
    Zhu W; Sun L; Zhao P; Liu Y; Zhang J; Zhang Y; Hong Y; Zhu Y; Lu Y; Zhao W; Chen X; Zhang F
    J Nanobiotechnology; 2021 Feb; 19(1):61. PubMed ID: 33639970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis.
    Liang JN; Zou X; Fang XH; Xu JD; Xiao Z; Zhu JN; Li H; Yang J; Zeng N; Yuan SJ; Pan R; Fu YH; Zhang M; Luo JF; Wang S; Shan ZX
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2441-2450. PubMed ID: 31175931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Xu Z; Mei F; Liu H; Sun C; Zheng Z
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
    Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
    Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
    Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
    Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy.
    Yin X; Peng C; Ning W; Li C; Ren Z; Zhang J; Gao H; Zhao K
    Mol Cell Biochem; 2013 Jul; 379(1-2):1-6. PubMed ID: 23660952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
    Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
    J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
    Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
    Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
    Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J
    J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy.
    Xu M; Wan CX; Huang SH; Wang HB; Fan D; Wu HM; Wu QQ; Ma ZG; Deng W; Tang QZ
    Cell Death Dis; 2019 May; 10(6):403. PubMed ID: 31127082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.